{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T21:18:42Z","timestamp":1770758322502,"version":"3.50.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T00:00:00Z","timestamp":1348531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/nrclinonc.2012.166","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T10:22:23Z","timestamp":1348568543000},"page":"654-665","source":"Crossref","is-referenced-by-count":34,"title":["Stereotactic body radiotherapy treatment of extracranial metastases"],"prefix":"10.1038","volume":"9","author":[{"given":"Joseph K.","family":"Salama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Fang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,25]]},"reference":[{"key":"BFnrclinonc2012166_CR1","first-page":"113","volume-title":"Principles and Practice of Oncology","author":"W Stetler\u2013Stevenson","year":"2005","unstructured":"Stetler\u2013Stevenson, W. in Cancer Principles and Practice of Oncology 7th edn (eds DeVita, V. T., Hellman S. & Rosenberg, S. A.) 113\u2013127 (Lippincott Williams and Wilkins, Philadelphia, 2005)."},{"key":"BFnrclinonc2012166_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1158\/0008-5472.CAN-07-6871","volume":"69","author":"PP Connell","year":"2009","unstructured":"Connell, P. P. & Hellman, S. Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res. 69, 383\u2013392 (2009).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2012166_CR3","first-page":"1677","volume":"25","author":"N Mehta","year":"2004","unstructured":"Mehta, N. et al. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int. J. Oncol. 25, 1677\u20131683 (2004).","journal-title":"Int. J. Oncol."},{"key":"BFnrclinonc2012166_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/02841860802662722","volume":"48","author":"KE Rusthoven","year":"2009","unstructured":"Rusthoven, K. E. et al. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Acta Oncol. 48, 578\u2013583 (2009).","journal-title":"Acta Oncol."},{"key":"BFnrclinonc2012166_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman, S. & Weichselbaum, R. R. Oligometastases. J. Clin. Oncol. 13, 8\u201310 (1995).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2012166_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","volume":"8","author":"RR Weichselbaum","year":"2011","unstructured":"Weichselbaum, R. R. & Hellman, S. Oligometastases revisited. Nat. Rev. Clin. Oncol. 8, 378\u2013382 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"BFnrclinonc2012166_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/jso.21102","volume":"98","author":"DM Macdermed","year":"2008","unstructured":"Macdermed, D. M., Weichselbaum, R. R. & Salama, J. K. A rationale for the targeted treatment of oligometastases with radiotherapy. J. Surg. Oncol. 98, 202\u2013206 (2008).","journal-title":"J. Surg. Oncol."},{"key":"BFnrclinonc2012166_CR8","doi-asserted-by":"crossref","unstructured":"The International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J. Thorac. Cardiovasc. Surg. 113, 37\u201349 (1997).","DOI":"10.1016\/S0022-5223(97)70397-0"},{"key":"BFnrclinonc2012166_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1200\/JCO.1997.15.3.938","volume":"15","author":"Y Fong","year":"1997","unstructured":"Fong, Y. et al. Liver resection for colorectal metastases. J. Clin. Oncol. 15, 938\u2013946 (1997).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2012166_CR10","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","volume":"26","author":"T Tanvetyanon","year":"2008","unstructured":"Tanvetyanon, T. et al. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J. Clin. Oncol. 26, 1142\u20131147 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2012166_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3171\/jns.1995.83.4.0605","volume":"83","author":"M Wron\u00b4ski","year":"1995","unstructured":"Wron\u00b4ski, M., Arbit, E., Burt, M. & Galicich, J. H. Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. J. Neurosurg. 83, 605\u2013616 (1995).","journal-title":"J. Neurosurg."},{"key":"BFnrclinonc2012166_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jamcollsurg.2007.04.039","volume":"205","author":"G Miller","year":"2007","unstructured":"Miller, G. et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J. Am. Coll. Surg. 205, 231\u2013238 (2007).","journal-title":"J. Am. Coll. Surg."},{"key":"BFnrclinonc2012166_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jamcollsurg.2005.11.008","volume":"202","author":"SA Shah","year":"2006","unstructured":"Shah, S. A. et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J. Am. Coll. Surg. 202, 468\u2013475 (2006).","journal-title":"J. Am. Coll. Surg."},{"key":"BFnrclinonc2012166_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3109\/02841869509127197","volume":"34","author":"H Blomgren","year":"1995","unstructured":"Blomgren, H., Lax, I., N\u00e4slund, I. & Svanstr\u00f6m, R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 34, 861\u2013870 (1995).","journal-title":"Acta Oncol."},{"key":"BFnrclinonc2012166_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3109\/02841869409121782","volume":"33","author":"I Lax","year":"1994","unstructured":"Lax, I., Blomgren, H., N\u00e4slund, I. & Svanstr\u00f6m, R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol. 33, 677\u2013683 (1994).","journal-title":"Acta Oncol."},{"key":"BFnrclinonc2012166_CR16","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jama.2010.261","volume":"303","author":"R Timmerman","year":"2010","unstructured":"Timmerman, R. et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303, 1070\u20131076 (2010).","journal-title":"JAMA"},{"key":"BFnrclinonc2012166_CR17","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","volume":"27","author":"MT Lee","year":"2009","unstructured":"Lee, M. T. et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J. Clin. Oncol. 27, 1585\u20131591 (2009).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2012166_CR18","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ijrobp.2011.08.036","volume":"83","author":"MT Milano","year":"2012","unstructured":"Milano, M. T., Katz, A. W., Zhang, H. & Okunieff, P. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J. Radiat. Oncol. Biol. Phys. 83, 878\u2013886 (2012).","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR19","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","volume":"27","author":"KE Rusthoven","year":"2009","unstructured":"Rusthoven, K. E. et al. Multi-institutional phase I\/II trial of stereotactic body radiation therapy for lung metastases. J. Clin. Oncol. 27, 1579\u20131584 (2009).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2012166_CR20","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","volume":"27","author":"KE Rusthoven","year":"2009","unstructured":"Rusthoven, K. E. et al. Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases. J. Clin. Oncol. 27, 1572\u20131578 (2009).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2012166_CR21","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1002\/cncr.26611","volume":"118","author":"JK Salama","year":"2012","unstructured":"Salama, J. K. et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 118, 2962\u20132970 (2012).","journal-title":"Cancer"},{"key":"BFnrclinonc2012166_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1470-2045(11)70384-9","volume":"13","author":"XS Wang","year":"2012","unstructured":"Wang, X. S. et al. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1\u20132 trial. Lancet Oncol. 13, 395\u2013402 (2012).","journal-title":"Lancet Oncol."},{"key":"BFnrclinonc2012166_CR23","doi-asserted-by":"publisher","unstructured":"Chawla, S., Schell, M. C. & Milano, M. T. Stereotactic body radiation for the spine: a review. Am. J. Clin. Oncol. http:\/\/dx.doi.org\/10.1097\/COC.0b013e31822dfd71 .","DOI":"10.1097\/COC.0b013e31822dfd71"},{"key":"BFnrclinonc2012166_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ijrobp.2007.11.046","volume":"71","author":"Y Yamada","year":"2008","unstructured":"Yamada, Y. et al. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int. J. Radiat. Oncol. Biol. Phys. 71, 484\u2013490 (2008).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/153303460200100106","volume":"1","author":"WF Regine","year":"2002","unstructured":"Regine, W. F. The radiation oncologist's perspective on stereotactic radiosurgery. Technol. Cancer Res. Treat. 1, 43\u201349 (2002).","journal-title":"Technol. Cancer Res. Treat."},{"key":"BFnrclinonc2012166_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/00006123-200003000-00002","volume":"46","author":"A Niranjan","year":"2000","unstructured":"Niranjan, A. & Lunsford, L. D. Radiosurgery: where we were, are, and may be in the third millennium. Neurosurgery 46, 531\u2013543 (2000).","journal-title":"Neurosurgery"},{"key":"BFnrclinonc2012166_CR27","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2012","unstructured":"Benedict, S. H. et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med. Phys. 37, 4078\u20134101 (2012).","journal-title":"Med. Phys."},{"key":"BFnrclinonc2012166_CR28","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2012)."},{"key":"BFnrclinonc2012166_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/COC.0b013e3180ca7cb1","volume":"30","author":"BK Chang","year":"2007","unstructured":"Chang, B. K. & Timmerman, R. D. Stereotactic body radiation therapy: a comprehensive review. Am. J. Clin. Oncol. 30, 637\u2013644 (2007).","journal-title":"Am. J. Clin. Oncol."},{"key":"BFnrclinonc2012166_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.radonc.2010.01.025","volume":"95","author":"K Han","year":"2010","unstructured":"Han, K. et al. A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors. Radiother. Oncol. 95, 103\u2013108 (2010).","journal-title":"Radiother. Oncol."},{"key":"BFnrclinonc2012166_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/153303460400300107","volume":"3","author":"M Fuss","year":"2004","unstructured":"Fuss, M. et al. Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapy. Technol. Cancer Res. Treat. 3, 59\u201367 (2004).","journal-title":"Technol. Cancer Res. Treat."},{"key":"BFnrclinonc2012166_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.semradonc.2003.10.006","volume":"14","author":"P Keall","year":"2004","unstructured":"Keall, P. 4-Dimensional computed tomography imaging and treatment planning. Semin. Radiat. Oncol. 14, 81\u201390 (2004).","journal-title":"Semin. Radiat. Oncol."},{"key":"BFnrclinonc2012166_CR33","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1118\/1.3658737","volume":"38","author":"J Cai","year":"2011","unstructured":"Cai, J., Chang, Z., Wang, Z., Paul Segars, W. & Yin, F. F. Four-dimensional magnetic resonance imaging (4D-MRI) using image-based respiratory surrogate: a feasibility study. Med. Phys. 38, 6384\u20136394 (2011).","journal-title":"Med. Phys."},{"key":"BFnrclinonc2012166_CR34","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ijrobp.2006.10.026","volume":"67","author":"P Kupelian","year":"2007","unstructured":"Kupelian, P. et al. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 67, 1088\u20131098 (2007).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR35","doi-asserted-by":"publisher","unstructured":"Ge, H., Cai, J., Kelsey, C. R. & Yin, F. Quantification and minimization of uncertainties of internal target volume (ITV) for stereotactic-body radiation therapy (SBRT) of lung cancer. Int. J. Radiat. Oncol. Biol. Phys. http:\/\/dx.doi.org\/10.1016\/j.ijrobp.2012.04.032 .","DOI":"10.1016\/j.ijrobp.2012.04.032"},{"key":"BFnrclinonc2012166_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000106030","volume":"40","author":"KK Brock","year":"2007","unstructured":"Brock, K. K. Image registration in intensity- modulated, image-guided and stereotactic body radiation therapy. Front. Radiat. Ther. Oncol. 40, 94\u2013115 (2007).","journal-title":"Front. Radiat. Ther. Oncol."},{"key":"BFnrclinonc2012166_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1748-717X-4-3","volume":"4","author":"QJ Wu","year":"2009","unstructured":"Wu, Q. J. et al. Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions. Radiat. Oncol. 4, 3 (2009).","journal-title":"Radiat. Oncol."},{"key":"BFnrclinonc2012166_CR38","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ijrobp.2009.05.005","volume":"75","author":"QJ Wu","year":"2009","unstructured":"Wu, Q. J., Yoo, S., Kirkpatrick, J. P., Thongphiew, D. & Yin, F. F. Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment. Int. J. Radiat. Oncol. Biol. Phys. 75, 1596\u20131604 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1118\/1.1842911","volume":"32","author":"JY Jin","year":"2005","unstructured":"Jin, J. Y., Yin, F. F., Ryu, S., Ajlouni, M. & Kim, J. H. Dosimetric study using different leaf-width MLCs for treatment planning of dynamic conformal arcs and intensity-modulated radiosurgery. Med. Phys. 32, 405\u2013411 (2005).","journal-title":"Med. Phys."},{"key":"BFnrclinonc2012166_CR40","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1088\/0031-9155\/48\/12\/307","volume":"48","author":"SB Jiang","year":"2003","unstructured":"Jiang, S. B. et al. An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments. Phys. Med. Biol. 48, 1773\u20131784 (2003).","journal-title":"Phys. Med. Biol."},{"key":"BFnrclinonc2012166_CR41","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1118\/1.4705353","volume":"39","author":"Y Tian","year":"2012","unstructured":"Tian, Y. et al. Dosimetric comparison of treatment plans based on free breathing, maximum, and average intensity projection CTs for lung cancer SBRT. Med. Phys. 39, 2754\u20132760 (2012).","journal-title":"Med. Phys."},{"key":"BFnrclinonc2012166_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.prro.2011.06.014","volume":"2","author":"T Solberg","year":"2012","unstructured":"Solberg, T. et al. Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: executive summary. Pract. Radiat. Oncol. 2, 2\u20139 (2012).","journal-title":"Pract. Radiat. Oncol."},{"key":"BFnrclinonc2012166_CR43","first-page":"3724","volume":"10","author":"JR Roper","year":"2012","unstructured":"Roper, J. R., Bowsher, J. E., Wilson, J. M., Turkington, T. G. & Yin, F. F. Target localization using scanner-acquired SPECT data. J. Appl. Clin. Med. Phys. 10, 3724 (2012).","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"BFnrclinonc2012166_CR44","unstructured":"Report of Task Group 104 of the Therapy Imaging Committee American Association of Physicists in Medicine. The Role of In-Room kV X-Ray 933 Imaging for Patient Setup and Target Localization [online] , (2009)."},{"key":"BFnrclinonc2012166_CR45","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/0360-3016(82)90459-X","volume":"8","author":"GW Barendsen","year":"1982","unstructured":"Barendsen, G. W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int. J. Radiat. Oncol. Biol. Phys. 8, 1981\u20131997 (1982).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR46","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1259\/0007-1285-58-690-515","volume":"58","author":"RG Dale","year":"1985","unstructured":"Dale, R. G. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br. J. Radiol. 58, 515\u2013528 (1985).","journal-title":"Br. J. Radiol."},{"key":"BFnrclinonc2012166_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2307\/3574407","volume":"66","author":"BG Douglas","year":"1976","unstructured":"Douglas, B. G. & Fowler, J. F. The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation. Radiat. Res. 66, 401\u2013426 (1976).","journal-title":"Radiat. Res."},{"key":"BFnrclinonc2012166_CR48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.semradonc.2008.04.004","volume":"18","author":"DJ Brenner","year":"2008","unstructured":"Brenner, D. J. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin. Radiat. Oncol. 18, 234\u2013239 (2008).","journal-title":"Semin. Radiat. Oncol."},{"key":"BFnrclinonc2012166_CR49","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1088\/0031-9155\/49\/20\/012","volume":"49","author":"M Guerrero","year":"2004","unstructured":"Guerrero, M. & Li, X. A. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys. Med. Biol. 49, 4825\u20134835 (2004).","journal-title":"Phys. Med. Biol."},{"key":"BFnrclinonc2012166_CR50","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1118\/1.3157095","volume":"36","author":"JP Kirkpatrick","year":"2009","unstructured":"Kirkpatrick, J. P., Brenner, D. J. & Orton, C. G. Point\/Counterpoint. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Med. Phys. 36, 3381\u20133384 (2009).","journal-title":"Med. Phys."},{"key":"BFnrclinonc2012166_CR51","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","volume":"18","author":"JP Kirkpatrick","year":"2008","unstructured":"Kirkpatrick, J. P., Meyer, J. J. & Marks, L. B. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin. Radiat. Oncol. 18, 240\u2013243 (2008).","journal-title":"Semin. Radiat. Oncol."},{"key":"BFnrclinonc2012166_CR52","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ijrobp.2007.10.059","volume":"70","author":"C Park","year":"2008","unstructured":"Park, C., Papiez, L., Zhang, S., Story, M. & Timmerman, R. D. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 70, 847\u2013852 (2008).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR53","doi-asserted-by":"publisher","first-page":"39ra48","DOI":"10.1126\/scitranslmed.3000864","volume":"2","author":"JZ Wang","year":"2010","unstructured":"Wang, J. Z., Huang, Z., Lo, S. S., Yuh, W. T. & Mayr, N. A. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci. Transl. Med. 2, 39ra48 (2010).","journal-title":"Sci. Transl. Med."},{"key":"BFnrclinonc2012166_CR54","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1126\/science.1082504","volume":"300","author":"M Garcia-Barros","year":"2003","unstructured":"Garcia-Barros, M. et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155\u20131159 (2003).","journal-title":"Science"},{"key":"BFnrclinonc2012166_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ccr.2005.07.014","volume":"8","author":"Z Fuks","year":"2005","unstructured":"Fuks, Z. & Kolesnick, R. Engaging the vascular component of the tumor response. Cancer Cell 8, 89\u201391 (2005).","journal-title":"Cancer Cell"},{"key":"BFnrclinonc2012166_CR56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0167-8140(02)00103-2","volume":"63","author":"JC Flickinger","year":"2002","unstructured":"Flickinger, J. C., Kondziolka, D., Maitz, A. H. & Lunsford, L. D. An analysis of the dose-response for arteriovenous malformation radiosurgery and other factors affecting obliteration. Radiother. Oncol. 63, 347\u2013354 (2002).","journal-title":"Radiother. Oncol."},{"key":"BFnrclinonc2012166_CR57","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0360-3016(99)00513-1","volume":"46","author":"JC Flickinger","year":"2000","unstructured":"Flickinger, J. C. et al. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. Int. J. Radiat. Oncol. Biol. Phys. 46, 1143\u20131148 (2000).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR58","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00066-004-1266-6","volume":"180","author":"S Levegr\u00fcn","year":"2004","unstructured":"Levegr\u00fcn, S., Hof, H., Essig, M., Schlegel, W. & Debus, J. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: dose\/volume-response relations. Strahlenther. Onkol. 180, 758\u2013767 (2004).","journal-title":"Strahlenther. Onkol."},{"key":"BFnrclinonc2012166_CR59","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3171\/jns.1997.87.3.0352","volume":"87","author":"BF Schneider","year":"1997","unstructured":"Schneider, B. F., Eberhard, D. A. & Steiner, L. E. Histopathology of arteriovenous malformations after gamma knife radiosurgery. J. Neurosurg. 87, 352\u2013357 (1997).","journal-title":"J. Neurosurg."},{"key":"BFnrclinonc2012166_CR60","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","volume":"71","author":"BC Burnette","year":"2011","unstructured":"Burnette, B. C. et al. The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity. Cancer Res. 71, 2488\u20132496 (2011).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2012166_CR61","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ijrobp.2006.10.025","volume":"67","author":"AW Katz","year":"2007","unstructured":"Katz, A. W. et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int. J. Radiat. Oncol. Biol. Phys. 67, 793\u2013798 (2007).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR62","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/02841860600908954","volume":"45","author":"P Okunieff","year":"2006","unstructured":"Okunieff, P. et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol. 45, 808\u2013817 (2006).","journal-title":"Acta Oncol."},{"key":"BFnrclinonc2012166_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/SPI-07\/08\/151","volume":"7","author":"EL Chang","year":"2007","unstructured":"Chang, E. L. et al. Phase I\/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J. Neurosurg. Spine 7, 151\u2013160 (2007).","journal-title":"J. Neurosurg. Spine"},{"key":"BFnrclinonc2012166_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","volume":"75","author":"S Chawla","year":"2009","unstructured":"Chawla, S. et al. Stereotactic body radiotherapy for treatment of adrenal metastases. Int. J. Radiat. Oncol. Biol. Phys. 75, 71\u201375 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR65","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2217\/fon.10.165","volume":"7","author":"J Torok","year":"2011","unstructured":"Torok, J., Wegner, R. E., Burton, S. A. & Heron, D. E. Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy. Future Oncol. 7, 145\u2013151 (2011).","journal-title":"Future Oncol."},{"key":"BFnrclinonc2012166_CR66","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1002\/cncr.24412","volume":"115","author":"J Kao","year":"2009","unstructured":"Kao, J. et al. Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response. Cancer 115, 3571\u20133580 (2009).","journal-title":"Cancer"},{"key":"BFnrclinonc2012166_CR67","unstructured":"Corbin, K. et al. Feasibility and toxicity of hypofractionated image-guided radiotherapy for large volume limited metastatic disease practical radiation oncology. Pract. Radiat. Oncol. (in press)."},{"key":"BFnrclinonc2012166_CR68","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijrobp.2008.03.062","volume":"73","author":"R McCammon","year":"2009","unstructured":"McCammon, R. et al. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 73, 112\u2013118 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR69","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/JTO.0b013e31824166a5","volume":"7","author":"MD Hasselle","year":"2012","unstructured":"Hasselle, M. D. et al. Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. J. Thorac. Oncol. 7, 376\u2013381 (2012).","journal-title":"J. Thorac. Oncol."},{"key":"BFnrclinonc2012166_CR70","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2012)."},{"key":"BFnrclinonc2012166_CR71","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.radonc.2009.03.005","volume":"91","author":"MT Milano","year":"2009","unstructured":"Milano, M. T. et al. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. Radiother. Oncol. 91, 301\u2013306 (2009).","journal-title":"Radiother. Oncol."},{"key":"BFnrclinonc2012166_CR72","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","volume":"78","author":"KA Goodman","year":"2010","unstructured":"Goodman, K. A. et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int. J. Radiat. Oncol. Biol. Phys. 78, 486\u2013493 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR73","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1080\/02841860600904821","volume":"45","author":"J Wulf","year":"2006","unstructured":"Wulf, J. et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol. 45, 838\u2013847 (2006).","journal-title":"Acta Oncol."},{"key":"BFnrclinonc2012166_CR74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0167-8140(02)00372-9","volume":"66","author":"J Wulf","year":"2003","unstructured":"Wulf, J., H\u00e4dinger, U., Oppitz, U., Thiele, W. & Flentje, M. Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver. Radiother. Oncol. 66, 141\u2013150 (2003).","journal-title":"Radiother. Oncol."},{"key":"BFnrclinonc2012166_CR75","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0360-3016(03)00586-8","volume":"57","author":"KK Herfarth","year":"2003","unstructured":"Herfarth, K. K. et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int. J. Radiat. Oncol. Biol. Phys. 57, 444\u2013451 (2003).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR76","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.semradonc.2011.05.006","volume":"21","author":"TE Schefter","year":"2011","unstructured":"Schefter, T. E. & Kavanagh, B. D. Radiation therapy for liver metastases. Semin. Radiat. Oncol. 21, 264\u2013270 (2011).","journal-title":"Semin. Radiat. Oncol."},{"key":"BFnrclinonc2012166_CR77","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ijrobp.2008.07.032","volume":"73","author":"CC Olsen","year":"2009","unstructured":"Olsen, C. C. et al. Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 73, 1414\u20131424 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR78","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1016\/j.ijrobp.2012.02.008","volume":"83","author":"MA Stinauer","year":"2012","unstructured":"Stinauer, M. A., Diot, Q., Westerly, D. C., Schefter, T. E. & Kavanagh, B. D. Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases. Int. J. Radiat. Oncol. Biol. Phys. 83, e613\u2013e618 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR79","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.ijrobp.2008.06.1949","volume":"73","author":"JW Nelson","year":"2009","unstructured":"Nelson, J. W. et al. Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. Int. J. Radiat. Oncol. Biol. Phys. 73, 1369\u20131375 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR80","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/cncr.22442","volume":"109","author":"S Ryu","year":"2007","unstructured":"Ryu, S. et al. Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery. Cancer 109, 628\u2013636 (2007).","journal-title":"Cancer"},{"key":"BFnrclinonc2012166_CR81","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ijrobp.2008.02.060","volume":"71","author":"A Sahgal","year":"2008","unstructured":"Sahgal, A., Larson, D. A. & Chang, E. L. Stereotactic body radiosurgery for spinal metastases: a critical review. Int. J. Radiat. Oncol. Biol. Phys. 71, 652\u2013665 (2008).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR82","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1586\/era.11.169","volume":"11","author":"GL Masucci","year":"2011","unstructured":"Masucci, G. L. et al. Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practice. Expert Rev. Anticancer Ther. 11, 1923\u20131933 (2011).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"BFnrclinonc2012166_CR83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijrobp.2004.09.006","volume":"62","author":"Y Yamada","year":"2005","unstructured":"Yamada, Y. et al. Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: a preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 62, 53\u201361 (2005).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR84","first-page":"e6","volume":"3","author":"B Teh","year":"2007","unstructured":"Teh, B. et al. The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed. Imaging Interv. J. 3, e6 (2007).","journal-title":"Biomed. Imaging Interv. J."},{"key":"BFnrclinonc2012166_CR85","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/02841860600904854","volume":"45","author":"M Hoyer","year":"2006","unstructured":"Hoyer, M. et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol. 45, 823\u2013830 (2006).","journal-title":"Acta Oncol."},{"key":"BFnrclinonc2012166_CR86","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1158\/1078-0432.CCR-08-0358","volume":"14","author":"JK Salama","year":"2008","unstructured":"Salama, J. K. et al. An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin. Cancer Res. 14, 5255\u20135259 (2008).","journal-title":"Clin. Cancer Res."},{"key":"BFnrclinonc2012166_CR87","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ijrobp.2008.04.073","volume":"73","author":"MT Milano","year":"2009","unstructured":"Milano, M. T., Philip, A. & Okunieff, P. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses. Int. J. Radiat. Oncol. Biol. Phys. 73, 832\u2013837 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR88","unstructured":"Metcalfe, S. K. et al. Prospective trial of stereotactic body radiation therapy for colorectal oligometastases. Proc. Amer. Radium Soc. S059 (2010)."},{"key":"BFnrclinonc2012166_CR89","doi-asserted-by":"publisher","first-page":"e28650","DOI":"10.1371\/journal.pone.0028650","volume":"6","author":"YA Lussier","year":"2011","unstructured":"Lussier, Y. A. et al. MicroRNA expression characterizes oligometastasis(es). PLoS One 6, e28650 (2011).","journal-title":"PLoS One"},{"key":"BFnrclinonc2012166_CR90","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2011)."},{"issue":"Suppl.","key":"BFnrclinonc2012166_CR91","doi-asserted-by":"publisher","first-page":"S445","DOI":"10.1016\/j.ijrobp.2009.07.1017","volume":"75","author":"P Cheruvu","year":"2009","unstructured":"Cheruvu, P. et al. Comparison of outcomes in patients with stage III versus oligometastatic stage IV non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 75 (Suppl.), S445 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR92","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2012)."},{"key":"BFnrclinonc2012166_CR93","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2012)."},{"key":"BFnrclinonc2012166_CR94","unstructured":"De Ruysscher, D. et al. Radical treatment of non-small cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (NCT01282450). J. Thorac. Oncol. (in press)."},{"key":"BFnrclinonc2012166_CR95","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10549-008-0157-4","volume":"115","author":"MT Milano","year":"2009","unstructured":"Milano, M. T., Zhang, H., Metcalfe, S. K., Muhs, A. G. & Okunieff, P. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res. Treat. 115, 601\u2013608 (2009).","journal-title":"Breast Cancer Res. Treat."},{"key":"BFnrclinonc2012166_CR96","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/bjs.6895","volume":"97","author":"AE van der Pool","year":"2010","unstructured":"van der Pool, A. E. et al. Stereotactic body radiation therapy for colorectal liver metastases. Br. J. Surg. 97, 377\u2013382 (2010).","journal-title":"Br. J. Surg."},{"issue":"Suppl.","key":"BFnrclinonc2012166_CR97","doi-asserted-by":"publisher","first-page":"S316","DOI":"10.1016\/j.ijrobp.2010.07.752","volume":"78","author":"P Cheruvu","year":"2010","unstructured":"Cheruvu, P. et al. Retrospective review of stereotactic body radiotherapy (SBRT) for lung metastases from colorectal cancer (CRC). Int. J. Radiat. Oncol. Biol. Phys. 78 (Suppl.), S316 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR98","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000201932","volume":"76","author":"MS Kim","year":"2009","unstructured":"Kim, M. S. et al. Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer. Oncology 76, 212\u2013219 (2009).","journal-title":"Oncology"},{"key":"BFnrclinonc2012166_CR99","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10585-010-9325-0","volume":"27","author":"JK Kang","year":"2010","unstructured":"Kang, J. K. et al. Oligometastases confined one organ from colorectal cancer treated by SBRT. Clin. Exp. Metastasis 27, 273\u2013278 (2010).","journal-title":"Clin. Exp. Metastasis"},{"key":"BFnrclinonc2012166_CR100","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1002\/cncr.25997","volume":"117","author":"DT Chang","year":"2011","unstructured":"Chang, D. T. et al. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 117, 4060\u20134069 (2011).","journal-title":"Cancer"},{"key":"BFnrclinonc2012166_CR101","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/annonc\/mdq385","volume":"22","author":"B Engels","year":"2011","unstructured":"Engels, B. et al. Phase II study of helical tomotherapy for oligometastatic colorectal cancer. Ann. Oncol. 22, 362\u2013368 (2011).","journal-title":"Ann. Oncol."},{"key":"BFnrclinonc2012166_CR102","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000091952","volume":"83","author":"PC Gerszten","year":"2005","unstructured":"Gerszten, P. C., Burton, S. A., Quinn, A. E., Agarwala, S. S. & Kirkwood, J. M. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact. Funct. Neurosurg. 83, 213\u2013221 (2005).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"BFnrclinonc2012166_CR103","doi-asserted-by":"publisher","unstructured":"Ranck, M. et al. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma. Am. J. Clin. Oncol. http:\/\/dx.doi.org\/10.1097\/COC.0b013e31825d52b2 .","DOI":"10.1097\/COC.0b013e31825d52b2"},{"key":"BFnrclinonc2012166_CR104","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.ijrobp.2010.11.052","volume":"82","author":"S Dhakal","year":"2011","unstructured":"Dhakal, S. et al. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. Int. J. Radiat. Oncol. Biol. Phys. 82, 940\u2013945 (2011).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR105","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1227\/NEU.0b013e31822b2fdc","volume":"69","author":"H Kano","year":"2011","unstructured":"Kano, H. et al. Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases. Neurosurgery 69, 1232\u20131239 (2011).","journal-title":"Neurosurgery"},{"key":"BFnrclinonc2012166_CR106","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3171\/2010.5.JNS1014","volume":"114","author":"DN Liew","year":"2011","unstructured":"Liew, D. N. et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J. Neurosurg. 114, 769\u2013779 (2011).","journal-title":"J. Neurosurg."},{"key":"BFnrclinonc2012166_CR107","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3171\/spi.2005.3.4.0288","volume":"3","author":"PC Gerszten","year":"2005","unstructured":"Gerszten, P. C. et al. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J. Neurosurg. Spine 3, 288\u2013295 (2005).","journal-title":"J. Neurosurg. Spine"},{"key":"BFnrclinonc2012166_CR108","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1748-717X-6-34","volume":"6","author":"MA Stinauer","year":"2011","unstructured":"Stinauer, M. A. et al. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat. Oncol. 6, 34 (2011).","journal-title":"Radiat. Oncol."},{"key":"BFnrclinonc2012166_CR109","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.radonc.2005.03.022","volume":"77","author":"PJ Wers\u00e4ll","year":"2005","unstructured":"Wers\u00e4ll, P. J. et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother. Oncol. 77, 88\u201395 (2005).","journal-title":"Radiother. Oncol."},{"key":"BFnrclinonc2012166_CR110","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1200\/JCO.2008.20.1293","volume":"27","author":"RJ Motzer","year":"2009","unstructured":"Motzer, R. J. et al. Overall survival and updated results for sunitinib compared with interferon \u03b1 in patients with metastatic renal cell carcinoma. J. Clin. Oncol. 27, 3584\u20133590 (2009).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2012166_CR111","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1200\/JCO.2008.19.5511","volume":"27","author":"B Escudier","year":"2009","unstructured":"Escudier, B. et al. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J. Clin. Oncol. 27, 3312\u20133318 (2009).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2012166_CR112","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa066838","volume":"356","author":"G Hudes","year":"2007","unstructured":"Hudes, G. et al. Temsirolimus, interferon \u03b1, or both for advanced renal-cell carcinoma. N. Engl. J. Med. 356, 2271\u20132281 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2012166_CR113","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/cncr.11243","volume":"97","author":"MT Ballo","year":"2003","unstructured":"Ballo, M. T. et al. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer 97, 1789\u20131796 (2003).","journal-title":"Cancer"},{"key":"BFnrclinonc2012166_CR114","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711\u2013723 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2012166_CR115","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u20132454 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2012166_CR116","doi-asserted-by":"publisher","first-page":"137ra174","DOI":"10.1126\/scitranslmed.3003649","volume":"4","author":"SK Seung","year":"2012","unstructured":"Seung, S. K. et al. Phase 1 study of stereotactic body radiotherapy and interleukin-2\u2014tumor and immunological responses. Sci. Transl. Med. 4, 137ra174 (2012).","journal-title":"Sci. Transl. Med."},{"key":"BFnrclinonc2012166_CR117","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2012)."},{"key":"BFnrclinonc2012166_CR118","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2012)."},{"key":"BFnrclinonc2012166_CR119","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2011)."},{"key":"BFnrclinonc2012166_CR120","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1056\/NEJMoa1112824","volume":"366","author":"MA Postow","year":"2012","unstructured":"Postow, M. A. et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N. Engl. J. Med. 366, 925\u2013931 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2012166_CR121","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1084\/jem.20062056","volume":"204","author":"B Zhang","year":"2007","unstructured":"Zhang, B. et al. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J. Exp. Med. 204, 49\u201355 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrclinonc2012166_CR122","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1016\/j.ijrobp.2012.01.080","volume":"1","author":"BW Cox","year":"2012","unstructured":"Cox, B. W., Jackson, A., Hunt, M., Bilsky, M. & Yamada, Y. Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 1, e661\u2013667 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR123","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","volume":"81","author":"FM Kong","year":"2011","unstructured":"Kong, F. M. et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int. J. Radiat. Oncol. Biol. Phys. 81, 1442\u20131457 (2011).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR124","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","volume":"18","author":"RD Timmerman","year":"2008","unstructured":"Timmerman, R. D. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin. Radiat. Oncol. 18, 215\u2013222 (2008).","journal-title":"Semin. Radiat. Oncol."},{"issue":"Suppl. 3","key":"BFnrclinonc2012166_CR125","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","volume":"76","author":"BD Kavanagh","year":"2010","unstructured":"Kavanagh, B. D. et al. Radiation dose-volume effects in the stomach and small bowel. Int. J. Radiat. Oncol. Biol. Phys. 76 (Suppl. 3), S101\u2013S107 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR126","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","volume":"76","author":"CC Pan","year":"2010","unstructured":"Pan, C. C. et al. Radiation-associated liver injury. Int. J. Radiat. Oncol. Biol. Phys. 76, S94\u2013S100 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR127","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.radonc.2009.04.018","volume":"93","author":"JA Forquer","year":"2009","unstructured":"Forquer, J. A. et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. Radiother. Oncol. 93, 408\u2013413 (2009).","journal-title":"Radiother. Oncol."},{"key":"BFnrclinonc2012166_CR128","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ijrobp.2009.02.027","volume":"76","author":"NE Dunlap","year":"2010","unstructured":"Dunlap, N. E. et al. Chest wall volume receiving >30 Gy predicts risk of severe pain and\/or rib fracture after lung stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 76, 796\u2013801 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"Suppl. 3","key":"BFnrclinonc2012166_CR129","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.ijrobp.2009.04.095","volume":"76","author":"JP Kirkpatrick","year":"2010","unstructured":"Kirkpatrick, J. P., van der Kogel, A. J. & Schultheiss, T. E. Radiation dose-volume effects in the spinal cord. Int. J. Radiat. Oncol. Biol. Phys. 76 (Suppl. 3), S42\u2013S49 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR130","doi-asserted-by":"publisher","unstructured":"Sahgal, A. et al. Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int. J. Radiat. Oncol. Biol. Phys. http:\/\/dx.doi.org\/10.1016\/j.ijrobp.2012.05.007 .","DOI":"10.1016\/j.ijrobp.2012.05.007"},{"key":"BFnrclinonc2012166_CR131","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ijrobp.2009.05.023","volume":"77","author":"A Sahgal","year":"2010","unstructured":"Sahgal, A. et al. Spinal cord tolerance for stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 77, 548\u2013553 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnrclinonc2012166_CR132","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.radonc.2005.09.003","volume":"77","author":"J Wulf","year":"2005","unstructured":"Wulf, J., Baier, K., Mueller, G. & Flentje, M. P. Dose-response in stereotactic irradiation of lung tumors. Radiother. Oncol. 77, 83\u201387 (2005).","journal-title":"Radiother. Oncol."},{"key":"BFnrclinonc2012166_CR133","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.radonc.2006.11.023","volume":"82","author":"IC Gibbs","year":"2007","unstructured":"Gibbs, I. C. et al. Image-guided robotic radiosurgery for spinal metastases. Radiother. Oncol. 82, 185\u2013190 (2007).","journal-title":"Radiother. Oncol."},{"key":"BFnrclinonc2012166_CR134","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1748-717X-6-80","volume":"6","author":"P Cheruvu","year":"2011","unstructured":"Cheruvu, P. et al. Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer. Radiat. Oncol. 6, 80 (2011).","journal-title":"Radiat. Oncol."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2012.166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2012.166","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2012.166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:20:06Z","timestamp":1684466406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2012.166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,25]]},"references-count":134,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["BFnrclinonc2012166"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2012.166","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,25]]}}}